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Abstract 
Diabetes is associated with an increased risk for brain disorders, namely cognitive 
impairments associated with hippocampal dysfunction underlying diabetic encephalopathy. 
However, the impact of a prediabetes state on cognitive function is unknown. Therefore, we 
now investigated whether spatial learning and memory deficits and the underlying 
hippocampal dysfunction were already present in a prediabetes animal model. Adult Wistar 
rats drinking high-sucrose (HSu) diet (35% sucrose solution during nine weeks) were 
compared to controls drinking water. HSu rats exhibited fasting normoglycemia accompanied 
by hyperinsulinemia and hypertriglyceridemia in the fed state, and insulin resistance with 
impaired glucose tolerance confirming them as a prediabetes rodent model. HSu rats 
displayed a poorer performance in hippocampal-dependent short- and long-term spatial 
memory performance, assessed with the modified Y-maze and Morris water maze tasks, 
respectively; this was accompanied by a reduction of insulin receptor-β density with normal 
levels of insulin receptor substrate-1 pSer636/639, and decreased hippocampal glucocorticoid 
receptor levels without changes of the plasma corticosterone levels. Importantly, HSu animals 
exhibited increased hippocampal levels of AMPA and NMDA receptor subunits GluA1 and 
GLUN1, respectively, whereas the levels of proteins markers related to nerve terminals 
(synaptophysin) and oxidative stress/inflammation (HNE, RAGE, TNF-α) remained 
unaltered. These findings indicate that 9 weeks of sucrose consumption resulted in a 
metabolic condition suggestive of a prediabetic state, which translated into short- and long-
term spatial memory deficits accompanied by alterations in hippocampal glutamatergic 
neurotransmission and abnormal glucocorticoid signaling. 
 
Keywords 
Diabetic encephalopathy, High-sucrose diet, Prediabetes, Hippocampus, Memory  
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Abbreviations: AUC, area under the curve; BBB, blood-brain barrier; Cont, control; GFAP, 
glialfibrillary acidic protein; GR, glucocorticoid receptor; GS, glutamine synthetase; GTT, 
glucose tolerance test; HbA1c, glycated hemoglobin; HOMA, homeostasis model assessment 
index; ITT, insulin tolerance test; HSu,  high-sucrose; HNE, hydroxynonenal; LTP, long-term 
potentiation; T2DM, type 2 diabetes mellitus; RAGE, receptor for advanced glycation end 
products, TC, serum total cholesterol; TGs,  triglycerides; TNF-α, tumor necrosis factor α.  
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1. Introduction  
 The development of type 2 diabetes mellitus (T2DM) is associated with an increased 
risk for brain disorders (Bruehl et al. 2009; Gold et al. 2007). In particular, a growing body of 
evidence indicates an increased risk of developing cognitive decline and dementia in a T2DM 
setting (Ravona-Springer et al. 2012; Roriz-Filho et al. 2009; Xu et al. 2010). T2DM triggers 
a condition of “diabetic encephalopathy” characterized by electrophysiological, structural and 
neurochemical changes leading to cognitive impairments (Biessels et al. 2002; Hernández-
Fonseca et al. 2009; Mijnhout et al. 2006; Ristow 2004; Sima 2010). Indeed, memory deficits 
seem to be the most reliable altered cognitive function in T2DM and seem to have an early 
onset (Gold et al. 2007; Strachan et al. 1997; Winocur et al. 2005).  
 These T2DM cognitive deficits have been argued to be due in large part to an impaired 
central insulin modulation in the hippocampus, which is a critical region for memory 
processing (McNay and Recknagel 2011). In fact, adults with newly diagnosed prediabetes or 
T2DM show an insulin resistance associated with reductions in regional cerebral glucose 
metabolism and subtle cognitive impairments (Baker et al. 2011). Interestingly, the insulin 
signaling overlaps with pathways that regulate both synaptic plasticity and memory processes 
(Kamal et al. 2000; McNay and Recknagel 2011; van der Heide et al. 2006). Therefore, it is 
not surprising that insulin has effects on memory storage and synaptic physiology (Costello et 
al. 2012; McNay et al. 2010; van der Heide et al. 2006).  
Accordingly, the preclinical animal studies investigating the relationship between T2DM 
and cognition have identified mild cognitive deficits (Bélanger et al. 2004; Duarte et al. 2012; 
Li et al. 2002; Winocur et al. 2005) typified by spatial learning and memory impairments in 
association with reduced hippocampal long-term potentiation, dendritic spine atrophy, 
decreased density of glutamatergic terminal markers and abnormal glutamatergic receptors 
regulation (Duarte et al. 2012; Trudeau et al. 2004). These diabetes-induced changes of 
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hippocampal-dependent memory and plasticity were proposed to result from the over-
activation of the abundant hippocampal glucocorticoid receptors (GR) (Dorey et al. 2012; 
Sousa and Almeida, 2002) by the enhanced levels of corticosterone (Stranahan et al. 2008a) 
arising from an hyper-activation of the hypothalamic–pituitary–adrenal (HPA) axis that is 
characteristic of diabetes (Hwang et al. 2011; Stranahan et al. 2008a).  
 Diabetes is an evolving clinical situation, which is recognized to develop from a 
situation of metabolic impairment often named as prediabetic state (Tabák et al. 2012). The 
diagnostic criteria for prediabetes include one or more of the following: impaired fasting 
glucose [IFG, plasma glucose of 100 to 125 mg/dL (5.6 to 6.9 mmol/L)], impaired glucose 
tolerance [IGT, plasma glucose of 140 to 199 mg/dL (7.8 to 11.0 mmol/L) 2 hours after an 
oral load of 75 g dextrose] or hemoglobin A1c 5.7% to 6.4% (Tabák et al. 2012). 
Additionally, insulin resistance is already present in the pre-diabetic stage. 
However, in contrast to T2DM, it is currently unknown if this condition of mild 
metabolic dysfunction is already associated with cognitive impairment. Therefore, the present 
study aimed at developing a model of metabolic dysfunction, based on the consumption of a 
high-sucrose (35% sucrose solution) diet during 9 weeks, to test if pre-diabetic rats displayed 
learning and memory deficits and an underlying hippocampal dysfunction. We found that 
metabolic changes suggestive of a pre-diabetic state translated into short- and long-term 
spatial memory deficits observed, respectively, in the Y-maze and Morris water maze tasks, 
and alterations on hippocampal glutamate receptors and GR levels. 
 
2. Experimental Procedures 
2.1. Animals and experimental procedures 
Male Wistar rats (4 months-old) were obtained from Charles River Laboratories (Barcelona, 
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Spain). The animals were housed two per cage, under controlled environmental conditions [12 
h light/dark cycle schedule under temperature (22±1 ºC) and humidity control]. After an 
adaptation period of 1 week, rats were randomly divided into two groups (n=8 animals per 
group), for a 9-weeks protocol: 1) control rats continued to drink tap water; 2) high-sucrose 
treated (HSu) rats received 35% sucrose (S0389; Sigma-Aldrich) in the drinking water. All 
animals were fed standard rat chow, containing 16.1% of protein, 3.1% of lipids, 3.9% of 
fibers and 5.1% of minerals (AO4 Panlab, Barcelona, Spain) ad libitum (with exception in the 
fasting periods). Food and beverage consumption was monitored for both groups throughout 
the experiment. The body weight of each animal was recorded weekly during the 
experimental period. All experiments were approved by the Institutional Animal Care and 
Use Committee from Faculty of Medicine, Coimbra University, and were performed 
following the European Community directive (2010/63/EU). All the animals were used for 
metabolic characterization (see Table 1) and behavioral assays, and within each group, 5 rats 
were used for neurochemical analysis. 
2.2. Behavioral tasks 
After 9 weeks, the short- and long-term spatial memories of control and HSu rats were 
assessed with a modified Y-maze and a Morris water maze, respectively. After habituation for 
at least 1 h before the beginning of the tests, behavior was monitored through a video camera 
positioned above the apparatuses and the images were later analyzed with the ANY Maze 
video tracking (Stoelting Co., Wood Dale, IL, USA) by an experienced investigator who was 
unaware of the experimental group being tested. 
2.2.1. Water maze task 
To evaluate the existence of long-term spatial memory deficits in HSu vs. control rats, the 
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animals were submitted to a spatial reference memory version of the water maze using a 
protocol described by Morris et al. (1982) and previously utilized in our laboratory (Castro et 
al. 2013). Tests were performed in a circular swimming pool made of black painted 
fibreglass, with 1.2 m internal diameter and 0.8 m height, and filled with water at 25°C to a 
depth of 0.6 m width. The target platform (10×10 cm) was made of transparent Plexiglas and 
was submerged 1–1.5 cm beneath the surface of the water. Starting points for the animals 
were marked on the outside of the pool as north (N), south (S), east (E) and west (W). Four 
distant visual cues (55×55 cm) were placed on the walls of the water maze room. They were 
all positioned with the lower edge 30 cm above the upper edge of the water tank, and in the 
standard setting the position of each symbol marked the midpoint of the perimeter of a 
quadrant (circle = NE quadrant, square = SE quadrant, cross = SW quadrant, and diamond = 
NW quadrant). The protocol consisted of 4 training days, four consecutive trials per day, 
during which the animals were left in the tank facing the wall, then being allowed to swim 
freely to the submerged platform placed in the centre of southwest quadrant of the tank. If the 
animal did not find the platform during a period of 60 s, it was gently guided to it. The animal 
was allowed to remain on the platform for 10 s after escaping to it and was then removed 
from the tank for 20 s before being placed at the next starting point in the tank. The apparatus 
was located in a room with indirect incandescent illumination. A monitor and a video-
recording system were installed in an adjacent room. The experiments were video-taped and 
the scores for latency of escape from the starting point to the platform and swimming speed 
were later measured using the ANY-maze® video tracking system. The test session was 
carried out 24 h later and consisted of a single probe trial where the platform was removed 
from the pool and each rat was allowed to swim for 60 s in the maze. The time spent in the 
correct quadrant (i.e., where the platform was located on the training session) and in the 
inverse quadrant, the latency to platform zone and the number of crossings in the platform 
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zone were recorded. 
2.2.2. Modified Y-maze task  
The modified Y-maze was used to assess short-term spatial memory and it is based on the 
innate preference of animals to explore areas that have not been previously explored (Cognato 
et al. 2010). The Y-maze apparatus consisted of three arms (50 x 10 x 40 cm) made of wood 
covered with impermeable formica elevated to a height of 50 cm above the floor. This task 
consisted of two trials (training and test) of 5 min separated by an inter-trial interval of 90 
min. During the training trial, one arm (“novel”) was blocked by a removable door and the rat 
was placed into the end of the one arm (“start”) facing the centre and it could chose between 
the start and the “other” arm. At the end of the training trial, the rat was removed from the 
maze and kept in an individual cage during the inter-trial interval (90 min). During the test 
trial, the “novel” arm was opened and the rat was once again placed in the start arm and 
allowed to explore the 3 arms during 5 min. The number of entries and the time spent in each 
arm were video monitored using ANY-maze TM tracking system. Entry into an arm was 
defined as placement of all 4 paws into the arm. The apparatus was cleaned with 10% ethanol 
between animals to avoid odor cues. 
2.3. Blood and tissue collection and preparation 
After the performance of the behavioral tasks, the animals were subjected to anesthesia with 
intraperitoneal (i.p.) injection of pentobarbital (50 mg/kg) (Sigma-Aldrich, Portugal) and 
blood samples were immediately collected by venipuncture from the jugular vein into 
syringes with Heparin-Lithium (Sarstedt, Monovette®) for plasma samples and into needles 
without anticoagulant for serum samples. Animals were then sacrificed by decapitation and 
the brains were immediately removed, placed in ice-cold Krebs buffer and carefully dissected. 
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9 
Hippocampal regions were immediately frozen in liquid nitrogen and stored at -80 ºC until 
Western blot analyses. 
2.4. Metabolic measurements 
Glucose tolerance test (GTT) was performed in fasted rats (6-h) injected with glucose (2 g/kg, 
i.p.). The tail vein blood glucose levels were measured using a portable device (One Touch 
UltraEasy® glucometer, Lifescan, Johnson and Johnson, Portugal) in samples immediately 
before the bolus, 0 and 15, 30, 60, and 120 min after the bolus. Glycemia was also measured 
in fed conditions. Insulin tolerance test (ITT) was performed after a single injection of insulin 
(0.75 U/kg, i.p.) (I9278, Sigma), in 6-h fasted rats, through monitoring the blood glucose 
before, 0 and 15, 30, 45, 60 and 120 min following the insulin injection using the same 
glucometer. Fasting insulin levels were quantified by using a rat insulin ELISA kit (Mercodia, 
Uppsala, Sweden). Insulin sensitivity of individual animals was evaluated using the 
homeostasis model assessment (HOMA) index (Matthews et al. 1985). The formula used was 
as follows: [HOMA-IR] = fasting serum glucose (mg/dL) × fasting serum insulin (μU/mL) / 
22.5. The values used (insulin and glucose) were obtained after an overnight fasting period. 
Serum total cholesterol (TC) and triglycerides (TGs) were analyzed by enzymatic methods 
using an automatic analyzer (Hitachi 717, Roche Diagnostics). Total-cholesterol reagents and 
TGs kits were obtained from bioMérieux (Lyon, France). Corticosterone plasma levels were 
analyzed using an ELISA kit (ab108821, Abcam, Cambridge, UK). 
2.5. Hippocampal neurochemical measurements 
Total extracts were obtained from the left hippocampus as previously described (Simões et al. 
2007). The hippocampus was homogenized in 400 μL of RIPA lysis buffer (150 mM NaCl; 
50 mM Tris-HCl pH=8.0; 5 mM EGTA; 1% Triton X-100; 0.5% DOC; 0.1% SDS) 
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10 
supplemented with a protease inhibitor cocktail (1 mM phenylmethylsulfonyl fluoride, 1 mM 
dithiothreitol, 1 μg/mL chymostatin, 1 μg/mL leupeptin, 1 μg/mL antipain, 5 μg/mL pepstatin 
A, 50 mM sodium fluoride and 1 mM sodium orthovanadate (Sigma-Aldrich) and centrifuged 
(15000 g, 15 min, 4ºC), to discard insoluble material. Total protein concentration was 
determined using the bicinchonic acid protein assay kit (Thermoscientific®) (Smith et al. 
1985) and supernatants were stored at -80 ºC until further use. Equal amounts of protein (5-75 
μg) were loaded and separated by electrophoresis on sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (7.5 - 12%), transferred to a 0.45 μm polyvinylidene difluoride (PVDF) 
membranes (Immobilon, Millipore, Madrid, Spain) and blocked with 1% bovine serum 
albumin (BSA) in phosphate buffer saline with 0.1% Tween-20 (PBS-T) for 1 h at room 
temperature. Membranes were then incubated overnight at 4ºC with the following primary 
antibodies against phospho-IRS-1 (Ser636/639, 1:1000), PSD-95 (1:1000) (both from Cell 
Signaling, MA, USA), IRS-1 (1:1000), GFAP (1:5000), GS (1:500), GluA1 (1:1000), 
GLUN1 (1:1000) and synpatophysin (1:1000) (all from Millipore MA, USA), RAGE 
(1:1000), TNF-α (1:600) (from Abcam, Cambridge, UK), IR-β (1:1000), GR (1:250) (from 
Santa Cruz, CA, USA) and HNE (1:1000) (from Calbiochem, Darmstadt, Germany). The 
membranes were washed extensively in 0.1% PBS-T and then incubated for 1 h at room 
temperature with alkaline phosphatase conjugated secondary antibodies [anti-rabbit and anti-
mouse (1:5000) from GE Healthcare, Carnaxide, Portugal]. Finally, membranes were 
visualized using a Typhoon FLA 900 (GE Healthcare Bio-sciences) imaging system, using an 
enhanced chemifluorescence detection reagent (ECF, GE Healthcare). To confirm equal 
protein loading and sample transfer, membranes were re-probed with β-actin (1:10,000, from 
Sigma-Aldrich) or GAPDH (1:5000, from Abcam) antibodies. Densitometric analyses were 
performed using the Image Quant 5.0 software. Results were normalized against β-actin or 
GAPDH, and then expressed as percentage of control. 
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2.6. Statistical analysis 
All values are expressed as means ± S.E.M. (n equals the number of rats). The comparisons of 
peripheral biochemical and hippocampal neurochemical changes and data of the Y-maze and 
probe test of the water maze were performed using an unpaired Student’s t-test. The statistical 
analysis of the data of the metabolic (GTT, ITT) and water maze training was carried out 
using one- or two-way analysis of variance (ANOVA) followed by post-hoc Newman-Keuls 
multiple comparison test. Further statistical analyses were performed by one-sample t-test 
comparing for each group the % of time and % of entries in each arm during the training and 
test trials of the modified Y-maze and the % of time spent in the correct and the opposite 
quadrants during the probe test session of the Morris water maze with the respective chance 
level. The accepted level of significance for the tests was P < 0.05. All tests were performed 
using the GraphPad Prism 5.0 software for Windows. 
 
3. Results 
3.1. Characterization of the prediabetic state triggered by high-sucrose diet in rats 
 High-sucrose consumption (HSu) during 9 weeks did not influence the body weight of 
treated rats (Table 1). It is noteworthy that although HSu rats consumed more liquid (P < 
0.001) compared to the control group (normal water), they ingested less chow (P < 0.001) 
(Table 1). However, HSu consumption induced an elevation on postprandial glycemia (P < 
0.05) while leaving fasting glycemia unaltered compared to the control group (Table 1). 
Insulin levels were also influenced by sucrose consumption as demonstrated by a significant 
increase (P < 0.001) in serum insulin in the HSu group (Table 1). When focusing on glucose 
tolerance, AUC-GTT from HSu rats was significantly higher (P < 0.05) compared to the 
control group (Table 1). Corroborating these observations, 120 min after insulin 
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administration, HSu rats displayed significantly higher blood glucose levels in the ITT (P < 
0.001) and HOMA-IR (P < 0.01) than control rats, thus confirming the insulin resistance 
(Table 1). Furthermore, glycated hemoglobin (HbA1c) from HSu rats was higher (P < 0.05) 
compared to controls (Table 1). HSu rats also showed elevated plasma triglycerides (P < 
0.05) but normal plasma total cholesterol (P > 0.05) levels when compared to the control 
group (Table 1). Additionally, plasma corticosterone levels were also normal (Table 1). 
3.2.The prediabetes state disrupted short- and long-term spatial memory 
 Two-way ANOVA (treatment vs. repeated measures) revealed no significant 
differences [F(1, 13)=0.25, P=0.62] between control and HSu rats to acquire the spatial 
information in the water maze, as indicated by similar escape latencies to find the platform 
during the training sessions (Fig. 1A). Moreover, one-sample t-test indicated that control rats 
spent more time in the correct quadrant (Fig. 1B) and less time in the opposite quadrant (Fig. 
1C) in comparison to chance performance (25%) during the probe test of the water maze 
(without platform), indicating that control rats were able to remember the platform location 
during the probe test session in the next day. On the other hand, a Student’s t-test indicated 
that during the probe test, HSu rats spent less time in the correct quadrant (Fig. 1B), more 
time in the opposite quadrant (Fig. 1C), had a higher latency to reach the platform zone (Fig. 
1D) and a reduced number of crossings in the platform zone (Fig. 1E) when compared to 
control rats. Altogether, these results indicate a selective deficit of long-term spatial memory, 
but not in spatial learning, after 9 weeks of high sucrose diet in rats.  
Since the performance in the modified Y-maze task is dependent of the exploratory 
behavior of the animals, we first evaluated the locomotor activity in the training trial. No 
significant differences were observed between control and HSu rats in the number of entries 
and the time spent in the two arms (“start” and “other”) (P > 0.05; Fig. 2A, B, C). One-sample 
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t-test analysis revealed that only control rats were able to recognize the “novel” arm as the 
unvisited arm in the previous trial, as indicated by the significant increase in the percentage of 
entries (Fig. 2E) and time (Fig. 2F) in the “novel” arm in comparison to chance performance 
(33.3%). More importantly, a Student’s t-test revealed short-term spatial memory deficits in 
HSu-treated rats as indicated by a significant reduction of the percentage of entries and time 
in the “novel” arm in comparison to control group (P < 0.05; Fig. 2E, F). 
3.3. Characterization of hippocampal alterations triggered by the high-sucrose diet  
3.3.1. The pre-diabetes state decreased the density of insulin receptors (IR-β) in the 
hippocampus  
 The suggested link between cognitive deficits and central insulin signaling led us to 
evaluate insulin markers in the hippocampus. High-sucrose consumption during 9 weeks 
induced a significant decrease in hippocampal IR-β levels (80.05.1%, n=5; P < 0.05) 
compared to controls (Fig. 3A). However, the immunoreactivity of both IRS-1 and IRS-1-
pSer636/639 in the hippocampus was not significantly altered (P > 0.05) in the HSu group 
(Fig. 3B,C). 
3.3.2. The pre-diabetes state induced an increase in the density of GluA1 and GLUN1 in the 
hippocampus 
 The spatial memory deficits observed in HSu rats warranted the study of hippocampal 
GluA1 and GLUN1 levels on account of their critical role in synaptic plasticity. The 
hippocampal levels of both GluA1 and GLUN1 were significantly increased in HSu rats 
(130.52.8%, n=5 and 152.15.3%, n=5, respectively; P < 0.05) when compared to control 
rats (Fig. 4 A,B). On the other hand, the levels of the post-synaptic glutamatergic marker 
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(PSD-95) remained unaltered (P > 0.05; Figure 4C). Moreover, the immunoreactivity of 
synaptophysin (a pre-synaptic vesicle protein) remained unchanged in the hippocampus from 
HSu compared to control rats (P > 0.05; Figure 4D). 
3.3.3. The pre-diabetes state induced a decrease in the density of GR in the hippocampus 
Since abnormal corticosterone signaling in the hippocampus has been proposed to 
underlie diabetes-associated memory impairment, we probed the density of glucocorticoid 
receptors (GR) in the hippocampus of HSu rats. It was found that the levels of GR were 
significantly decreased in the hippocampus of HSu rats when compared to control rats (60.0 ± 
5.2%, P < 0.05; Figure 4E). 
 
3.3.4. Evaluation of hippocampal oxidative stress/inflammation markers upon high-sucrose 
diet 
 Both oxidative stress and inflammation are two key players in diabetic 
encephalopathy. Therefore it was important to assess the levels of hydroxynonenal (HNE, a 
precursor for advanced lipoxidation end product-ALE), RAGE (receptor for advanced 
glycation end products), TNF-α, GFAP and GS (astrogliosis markers) in the hippocampus of 
HSu rats. However, no significant differences in any of these parameters were observed after 
9 weeks of high-sucrose exposure compared to control rats (Table 2).  
 
4. Discussion 
 Our results show for the first time that a pre-diabetes state in rats triggers short- and 
long-term spatial memory deficits observed in the modified Y-maze and Morris water maze 
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tasks, respectively, that are accompanied by a decrease of the levels of insulin receptors, 
changes in glutamatergic neurotransmission and a decrease of the levels of glucocorticoid 
receptor in the hippocampus. 
Diet is an important environmental determinant for life-style-related diseases such as 
T2DM (Steyn et al. 2004). Although numerous studies with rodents have already shown that a 
high-sucrose diet (HSu) induces insulin resistance and hypertriglyceridemia (Carvalho et al. 
2012; Conde et al. 2011; Kanazawa et al. 2003; Ribeiro et al. 2005; Sumiyoshi et al. 2011), 
the impact on brain functioning of pre-diabetic animal models, namely the HSu-treated rat, 
are scarce. The current findings indicate no significant differences on glycemia in the fasting 
state, but a marked increase in the fed glycemia (postprandial) in HSu-treated rats, together 
with impaired glucose tolerance (IGT), hyperinsulinemia and insulin resistance, all 
characteristic of a metabolic disease-like pre-diabetic condition (Tabák et al. 2012). These 
metabolic changes are in agreement with previous studies demonstrating sucrose-induced 
insulin resistance in rats with fasting normoglycemia (Thresher et al. 2000). Additionally, this 
pre-diabetic model is characterized by hypertriglyceridemia, without obesity and 
hypertension, as previously documented by other authors (Cao et al. 2007; Carvalho et al. 
2012; Kanazawa et al. 2003; Ribeiro et al. 2005; Santuré et al. 2002; Sumiyoshi et al. 2011). 
Taken together, these results confirm the current approach of high sucrose consumption 
during 9 weeks as a valuable model of pre-diabetes/insulin resistance, characterized by fasting 
normoglycemia, IGT, hyperinsulinemia, insulin resistance and hypertriglyceridemia, without 
obesity and hypertension. 
Some studies have linked insulin resistance and T2DM to deficits of hippocampal-
dependent memory function (Convit, 2005; Gold et al. 2007; Strachan et al. 1997; Winocur et 
al. 2005). Importantly, Gold et al. (2007) highlighted that memory impairments associated 
with hippocampal alterations represent some of the early brain complications in T2DM. In 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
           
 
 
16 
accordance with this view, our results showed that a pre-diabetic state disrupted hippocampal-
dependent short- and long-term spatial memories in rats evaluated in the modified Y-maze 
and Morris water maze tasks, respectively, without major alterations on spatial learning and 
locomotor activity. It is noteworthy that the modified Y-maze and the spatial version of the 
Morris water maze tests reliably probe, respectively, short- and long-term spatial memory 
performance (Castro et al. 2013; Duarte et al. 2006, 2012; Prediger et al. 2006). In fact, in 
both tests, the animals need to make associations among the spatial environmental cues to 
form a cognitive map that helps them to find the platform localization (Morris et al. 1982) or 
the previously unvisited arm (Dellu et al. 1997). Importantly, this modified Y maze test is 
non-aversive since it does not require either food deprivation (as opposed to the radial maze) 
or electrical foot-shock (as opposed to inhibitory avoidance task), which could modify the 
motivational and emotional status of the animal (Bekker et al. 2006), thus confounding the 
spatial memory parameters measured.  
 Memory deficits seen herein corroborate previous observation by Chepulis et al. 
(2009) that 9 and 12 months of exposure to 7.9% sucrose induced a significant decrease in the 
proportion of rats that recognized the novel arm as the unvisited arm of the Y-maze when 
compared to controls. Interestingly, Cao et al. (2007) reported insulin resistance and 
exacerbation of memory deficits in a transgenic mouse model of Alzheimer following 25 
weeks of 10%-sucrose-sweetened water intake. Moreover, other types of diet, including high-
fructose, that induce metabolic alterations were also able to promote marked memory 
impairments (McNay et al. 2010; Mielke et al. 2005; Molteni et al. 2002; Ross et al. 2009; 
Stranahan et al. 2008b; Winocur and Greenwood, 1999; Wu et al. 2003). Other studies 
showed that high-fat diets (41-59%; HFD) inducing stronger metabolic alterations compared 
with our model were not always associated with cognitive impairments (Leboucher et al. 
2013; Pistell et al. 2010). However, it should be stressed that these studies used a different 
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species (mice), behavioral paradigms [mean acquisition errors/Stone T-maze (Pistell et al. 
2010) and escape latency/path length /Morris water maze (Leboucher et al. 2013) as spatial 
learning read-outs] and different ages. In fact, Pistell and collaborators (2010) acknowledged 
that cognitive performance is known to decrease with age and that 12 month-old “control” 
mice might have mild impairments compared to younger mice thus masking a putative effect 
of a 41% fat regimen. They further indicated the need for a systematic evaluation of how 
increasing age might modulate cognitive function. Moreover, in contrast to our study, both 
studies only assessed spatial learning whereas we evaluated both spatial learning and 
memory. Notably, in our study, HSu also failed to display learning impairment as gauged by 
similar escape latency to find the platform during the training trials of the Morris water maze 
when compared with controls. Therefore one cannot exclude that these HFD could also 
induce spatial memory deficits as demonstrated by Kosary et al. (2012) using both Y maze 
and novel object recognition tests.  
It is worth noting that the present study cannot rule out the hypothesis that the fructose moiety 
of the sucrose disaccharide crosses the blood-brain barrier (BBB) (Cha and Lane, 2009) and 
may be accountable for sucrose-induced memory impairments observed in the current study. 
Furthermore, hypertriglyceridemia seen in the HSu group that could have been triggered by 
fructose may also contribute to the memory dysfunction observed herein. In support of this 
idea, direct injection of triglycerides into the brain has detrimental consequences for learning 
and memory (Farr et al. 2008) and insulin transport through the BBB (Banks et al. 2004; 
Banks et al. 2008; Urayama et al. 2008).  
Overall, it has been suggested that these memory deficits are probably due to a 
disruption of insulin signaling (Ristow, 2004; van der Heide et al. 2006). Considering that 
chronic peripheral hyperinsulinemia may down-regulate BBB insulin receptors thus reducing 
insulin transport into the brain (Banks 2004; Craft and Watson 2004; Wallum et al. 1987), we 
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cannot rule out the possibility of a reduction of hippocampal insulin levels in HSu animals. 
However, hippocampal insulin signaling can also be sustained by insulin synthesized by 
hippocampal pyramidal neurons (Kuwabara et al. 2011). There is no previous study 
addressing the impact of high sucrose treatment on the ability of hippocampal cells to produce 
insulin. Besides insulin levels, insulin signaling could also be affected in the hippocampus 
thus contributing to cognitive deficits exhibited by HSu rats. Indeed, we found a reduction in 
IR-β levels in HSu compared to control rats. This is consistent with IR expression being 
diminished in type-2 diabetic patients (Nisticò et al. 2012). On the other hand, Winocur and 
colleagues (2005) found no differences in the hippocampal IR-β expression on 
hyperinsulinemic ZDF rats, with 6 months of age. Moreover this decrease of IR-β levels in 
HSu rats was accompanied by a lack of alteration of IRS-1 pS636/639 levels, which is a 
known negative regulator of IRS-1 (Talbot et al. 2012). Therefore, our results suggest that, 
although there was a downregulation of the insulin receptor, hippocampal insulin response 
might not be affected. However, we cannot exclude that IRS-2 signaling could be 
compromised in HSu animals, since it was recently demonstrated that this insulin receptor 
substrate is also involved in hippocampal synaptic plasticity (Costello et al. 2012). 
 Impaired cognitive performance is also associated with disglycemia (Gao et al. 2008). 
One of the major key players that translate hyperglycemia into glucotoxicity is RAGE-
mediated inflammatory/oxidative stress pathways (Ramasay et al. 2005). Additionally, 
RAGE–mediated pathways have been implicated in memory deficits in Alzheimer’s disease 
(Arancio et al. 2004; Fang et al. 2010; Maczurek et al. 2008; Wilson, 2009). Nevertheless, 
sucrose-sweetened water did not increase fasting glycemia and, thus, glucose neurotoxicity 
ought not be held responsible for the memory deficits reported here. The RAGE levels in HSu 
rats were comparable to control rats, which is consistent with normoglycemia. Furthermore, 
we failed to observe any sign of hippocampal oxidative stress in such early pre-diabetic stage, 
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as gauged from the normal HNE found in the hippocampi of HSu rats when compared with 
control rats. The key pro-inflammatory cytokine TNF- was found to be over-expressed in 
diabetic hippocampi and was coupled with cognitive dysfunction (Liu et al. 2012). 
Additionally, RAGE up-regulation increases TNF- levels (Ramasay et al. 2005). 
Consistently with RAGE data, TNF- levels from HSu rats were not significantly different 
from control animals. The absence of an oxidative stress profile along with normal TNF- 
levels is consistent with the lack of synaptotoxicity as seen by normal synaptophysin levels in 
HSu when compared to control rats. Upon neurotoxicity, astrocytes can become reactive 
(Pekny and Wilson, 2005). Therefore, it is not surprising that we did not observe significant 
difference in the hippocampal GFAP and GS levels between HSu and control groups. 
Contrasting with our findings, Duarte et al., (2012) recently showed the association between 
the synaptotoxicity and astrogliosis with T2DM-induced memory impairment. However one 
should stress that these authors used a diabetic phenotype characterized by hyperglycemia 
whereas our model is normoglycemic, which suggests that astrogliosis is a feature 
characteristic of T2DM rather than of pre-diabetes. 
Other mechanisms underlying memory deficits should be considered. For example, it is now 
well established that adaptive changes in glutamatergic synapses, typified by modified 
densities of NMDAR and AMPAR, are tightly associated with synaptic plasticity and 
memory (Yashiro and Philpot, 2008; Santos et al. 2009). Although memory impairments and 
hippocampal glutamargic dysfunction have been associated with diabetic encephalopathy 
characteristic of T2DM (Trudeau et al. 2004), nothing is known about the regulation of 
GluA1 and GLUN1 subunits, that are crucial for synaptic plasticity phenomena (Lee, 2006), 
in pre-diabetic conditions. Remarkably, we now found an up-regulation of GluA1 and 
GLUN1 subunits in hippocampal total extracts of HSu compared to control rats. However, 
these alterations were not accompanied by significant changes on PSD-95, one of the 
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fundamental glutamatergic scaffolding proteins. This suggests that HSu rats have normal 
glutamatergic synaptic density. The up-regulation of both AMPA/NMDA subunits might be a 
compensatory mechanism to circumvent their defective activity underlying memory 
impairment. Interestingly, Turringiano and colleagues showed that the inhibition of synaptic 
transmission up-regulates AMPAR transcription (Turrigiano et al., 1998), presumably as a 
means of compensation. It is noteworthy that an up-regulation of both NMDA and AMPA 
receptors in thoracic spinal cord sections was observed at early stages of a mouse model that 
closely resembles type 2 (insulin-independent) diabetes of obese-diabetic ob/ob mice (Li et 
al., 1999). It was also reported that the up-regulation of hippocampal glutamate NMDAR and 
AMPAR accompanied synaptic plasticity defects in T1DM animal models as reviewed by 
Trudeau et al. (2004). Moreover memory impairments observed in this pre-diabetes state may 
also be underlined by changes in other ionotropic glutamate receptors (eg.  GluA2, GluN2A 
and GluN2B) levels as well as in their phosphorylation status and/or subcellular localization 
as observed in T1DM and T2DM experimental models (Di Luca et al. 1999; Trudeau et al. 
2004).  
Aberrant corticosterone signaling was also implied in diabetes induced memory deficits. In 
fact, Strahan et al. (2008a) demonstrated that high levels of circulating corticosterone 
contributed to diabetes impaired hippocampal-dependent memory and synaptic plasticity in 
both insulin–deficient rats and insulin–resistant (ob/ob) mice. Moreover it was recently shown 
that a GR antagonist (mifepristone) ameliorated cognitive dysfunction in streptozotocin 
(STZ)-induced type-1 diabetic rats (Zuo et al. 2011). However there is conflicting data on GR 
levels in diabetic models. While Goto–Kakizaki rats exhibited decreased GR immunolabeling 
in the CA1 area, associated with higher corticosteronemia (Beauquis et al. 2010), ZDF rats 
exhibited an increase in hippocampal GR levels (Hwang et al. 2011). Moreover, Shin et al. 
(2013) showed recently that hippocampal GR protein expression increased significantly until 
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the 3
rd
 week, but decreased at the 4
th
 week following STZ administration. At this moment, 
there is no information regarding corticosterone circulating levels and hippocampal GR levels 
in a pre-diabetic state. Notably, we now show that consumption of high sucrose for 9 weeks 
significantly decreased GR hippocampal levels when compared to control rats. Interestingly, 
this GR down-regulation was accompanied by normal corticosterone plasmatic levels. 
Whereas it is not unexpected that glucorticoids are still normal in a pre-diabetes state, this 
decrement of GR levels might lead to failure of feedback regulation of the HPA axis thereby 
contributing to mounting glucocorticoid levels putatively seen when evolving to a diabetes 
state. This mechanism was proposed to be operative in an early phase of Alzheimer’s disease 
mouse model where GR down-regulation coincided with the onset of memory decline in the 
object recognition test and preceded the increase in plasma levels of corticosterone (Escribano 
et al. 2008). Therefore, one cannot exclude that the adaptative change of hippocampal GR 
density seen herein might have contributed to the glutamatergic dysfunction and/or memory 
impairment exhibited by HSu rats.  
In conclusion, in the present study we confirm the deleterious effect of adding sucrose to a 
normal rodent diet, resulting in a pre-diabetic state, mainly characterized by fasting 
normoglycemia, hyperinsulinemia, insulin resistance, hypertriglyceridemia and impaired 
glucose tolerance compared with the control rats. Notably, we provide evidence showing that 
this condition of pre-diabetes was already associated with short- and long-term spatial 
memory impairments, which were underlined by a compromised glutamatergic as well as 
glucocorticoid function in the hippocampi from HSu rats. These data reinforce the suggestion 
that cognitive impairment is an early feature of T2DM, since it is already observed in 
conditions mimicking metabolic disease. Furthermore, it highlights the potential role of 
dietary sugar in the early central diabetic complications and suggests that controlling the 
consumption of sugar-sweetened beverages may be an effective way to curtail the risk of 
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developing T2DM. In this context, the identification of the mechanisms by which 
glutamatergic as well as glucocorticoid signaling contribute to “diabetic encephalopathy” 
might be of paramount clinical relevance. 
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Figure 1- Evaluation of spatial learning and long-term memory performance of high-sucrose 
(HSu) diet and control (Cont) rats using Morris water maze task (spatial reference memory 
version). (A) shows escape latency (s) to the platform  over four days of training; (B) shows 
time spent (%) in the correct quadrant (probe test); (C) shows time spent (%) in the opposite 
quadrant (probe test); (D) shows latency (s) to platform zone (probe  trial);  (E) shows the 
number of crossings  in  the platform zone  (probe  test). Data are presented as mean ± SEM 
of 8 animals per group. *, P < 0.05; **, P < 0.01; ***, P < 0.001, versus Cont group using an 
unpaired Student's t-test. #, P < 0.05; ##, P < 0.01, versus chance level (25% of time) using 
one-sample t-test.   
 
Figure 2 – Evaluation of short-term spatial memory performance of high-sucrose (HSu) diet 
group and control (Cont) rats using a modified Y-maze task. A training trial was performed to 
test exploratory capacity: (A) shows the total number of entries; (B) shows entries (%) in both 
Start and Other arms; (C) shows time spent (%) in both Start and Other arms. The same 
parameters were analyzed during test trial: (D) shows the total number of entries; (E) shows 
entries (%) in Start, Other and Novel arms; (F) shows time spent (%) in Start, Other and 
Novel arms. Data are presented as mean ± SEM of 8 animals per group. *, P < 0.05; **, P < 
0.01, versus Cont group using an unpaired Student's t-test.
 
#, P < 0.05, versus chance level 
(33.3% of time or entries) using one-sample t-test. 
 
Figure 3 - Hippocampal IR-β (A), IRS-1 (B) and IRS-1 pSer (636/639) (C) levels from high-
sucrose (HSu) diet and control (Cont) rats (measured by Western blot). High-sucrose 
decreased IR- levels (A) but IRS-1 (B) and IRS-1 pSer (636/639) (C) levels remained 
unchanged in the hippocampus. Data are presented as mean percentage of control ± SEM of 5 
animals per group. *, P < 0.05, **, P < 0.01, versus Cont group using an unpaired Student's t-
test. 
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Figure 4 - Hippocampal GluA1 (A), GLUN1 (B), PSD-95 (C), synaptophysin (D) and GR (E) 
levels from high-sucrose (HSu) diet and control (Cont) rats (measured by Western blot). 
High-sucrose increased both GluA1 (A) and GLUN1 (B) levels but PSD-95 (C) and 
synaptophysin (D) levels remained unchanged, whereas GR density was decreased in the 
hippocampus. Data are presented as mean percentage of control ± SEM of 5 animals per 
group. *, P < 0.05, versus Cont group using an unpaired Student's t-test. 
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Tables 
Table 1: Evaluation of biochemical peripheral parameters of high-sucrose (HSu) diet 
group and control (Cont) rats. 
Parameters Cont HSu 
Total Food Consumption (g) 1375 ± 2.9 519 ± 0.7*** 
Total Drink Consumption 
(mL) 
1833 ± 4.3 2878 ± 4.0*** 
Body weight (g) 421.0 ± 24.5 421.8 ± 20.3 
Postprandial glycemia 
(mg/dL) 
126.8 ± 13.6 162.9 ± 26.5* 
Fasting glycemia (mg/dL) 96.7 ± 4.5 102.9 ± 7.0 
Fasting Insulin levels (μg/L) 3.7 ± 1.8 10.8 ± 1.0*** 
Triglyceride levels (mg/dL) 68.1 ± 26.3 143.1 ± 65.7* 
Cholesterol levels (mg/dL) 63.7 ± 2.5 58.2 ± 9.7 
HbA1c (%) 3.7 ± 0.1
 
4.0 ± 0.2* 
HOMA-IR 2.7x10
-5
±1.5 x10
-5
 8.0 x10
-5 
± 9.0 x10
-6
** 
Glucose AUC-GTT 
(mg/dL/120 min) 
2.1 x10
4
 ± 1.0 x10
3
 2.6 x10
4
 ± 3.8 x10
3
* 
Glucose ITT 120 min (mg/dL) 37.2 ± 7.0 63.9 ± 14.8** 
Corticosterone levels (μg/mL) 0.541 ± 0.020 0.569 ± 0.041 
 
Data are expressed as mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared 
with Cont animals. 
  
Table 2: Hippocampal oxidative stress/inflammation markers from high-sucrose (HSu) diet 
and control (Cont) groups.  
Parameter Markers Cont HSu P value 
Astrogliosis 
GFAP 
100 ± 9 107± 14 0.6765 
GS 
100± 6 102± 8 0.8516 
Inflammation 
markers 
Oxidative stress 
TNF-α 
100 ± 7 107 ± 2 0.3257 
RAGE 
100 ± 11 107± 16 0.7196 
Lipid peroxidation 
HNE 
100± 8 103± 10 0.8235 
 
Data represent mean percentage of control ± SEM. 
 
 
 
  
Highlights 
- Short- and long-term spatial memory deficits are present in prediabetic rats. 
- Memory deficits are concurrent with increases of GluA1 and GLUN1 
hippocampal levels. 
- Prediabetic rats display decreased hippocampal IR-β density.  
- Memory deficits are concurrent with decreased GR hippocampal levels. 
 
 
